Skip to search formSkip to main contentSkip to account menu

Peptichemio

Known as: peptide bound m-L-sarcolysin, Peptichemio [Chemical/Ingredient], Multialchilpeptide 
A mixture of six synthetic oligopeptides in which the peptides are conjugated to metamelphalan, with alkylating and potential antineoplastic activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Alteration of the melphalan molecule by shifting the di(2-choroethyl)aminogroup from the para- to the meta-position of the… 
1987
1987
Sixty‐five children with neuroblastoma without evidence of distant metastases underwent initial tumor resection. Seventeen with… 
1985
1985
Twenty-five consecutive patients with previously untreated multiple myeloma were studied for bone marrow plasma cell labeling… 
1982
1982
PTC, a mixture of oligopeptides of m‐L‐sarcholysin, acting primarily as an alkylating agent, was utilized as initial therapy… 
1980
1980
A phase II trial of Peptichemio (PTC) was conducted on 56 patients with advanced breast cancer that had been resistant to… 
1979
1979
Peptichemio is a peptide complex of m-L-phenylalanine mustard. A clinical evaluation of this agent was conducted in 116 patients… 
1978
1978
Peptichemio (PTC) is a mixture of six synthetic peptides of m-L-phenylalanine mustard. It acts with both alkylating and… 
1978
1978
Peptichemio (PTC) was utilized in various advanced and disseminated tumors in children. With the schedule that was used, toxicity… 
1977
1977
Summary The lethal and cytokinetic effects of peptichemio (multipeptide complex of m -[di(2-chloroethyl)amino]-l-phenylalanine…